ANTARES PHARMA
Halozyme Therapeutics to acquire Antares Pharma in all-cash dealThe transaction, which values Antares at $960 million, demonstrates Halozyme's commitment to drug delivery.
Meet this maverick short seller whose favourite pastime is exposing ‘bad companies’Some of the most respected people in the investing industry say that nobody has had a better nose for sniffing out fraud than the 56-year-o...
- Load More